Joseph R. Sterbis

648 total citations
31 papers, 470 citations indexed

About

Joseph R. Sterbis is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Joseph R. Sterbis has authored 31 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 6 papers in Oncology. Recurrent topics in Joseph R. Sterbis's work include Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Joseph R. Sterbis is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (10 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Joseph R. Sterbis collaborates with scholars based in United States, Canada and Pakistan. Joseph R. Sterbis's co-authors include Leah P. McMann, Michael B. Lustik, David G. McLeod, Inger L. Rosner, Stephen A. Brassell, Yongmei Chen, Noah S. Schenkman, Jennifer Cullen, Timothy C. Brand and Kevin R. Rice and has published in prestigious journals such as Cancer, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Joseph R. Sterbis

27 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph R. Sterbis United States 15 223 219 94 43 41 31 470
Philipp Dahm United States 5 202 0.9× 240 1.1× 84 0.9× 80 1.9× 34 0.8× 9 481
Michael Probst Germany 12 208 0.9× 252 1.2× 102 1.1× 34 0.8× 16 0.4× 23 599
Hasan Bektaş Türkiye 14 345 1.5× 136 0.6× 118 1.3× 51 1.2× 18 0.4× 67 661
A. Doerfler France 13 147 0.7× 178 0.8× 81 0.9× 22 0.5× 19 0.5× 48 406
Francesco Persico Italy 18 362 1.6× 282 1.3× 140 1.5× 33 0.8× 33 0.8× 38 863
Nessn Azawi Denmark 12 340 1.5× 215 1.0× 55 0.6× 25 0.6× 27 0.7× 79 567
M.S. Michel Germany 12 156 0.7× 297 1.4× 48 0.5× 27 0.6× 58 1.4× 47 514
Isuru Jayaratna United States 10 269 1.2× 154 0.7× 55 0.6× 30 0.7× 136 3.3× 20 400
Alastair Henderson United Kingdom 16 192 0.9× 433 2.0× 65 0.7× 28 0.7× 23 0.6× 47 622
Danuta Dynda United States 13 250 1.1× 219 1.0× 119 1.3× 33 0.8× 15 0.4× 46 545

Countries citing papers authored by Joseph R. Sterbis

Since Specialization
Citations

This map shows the geographic impact of Joseph R. Sterbis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph R. Sterbis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph R. Sterbis more than expected).

Fields of papers citing papers by Joseph R. Sterbis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph R. Sterbis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph R. Sterbis. The network helps show where Joseph R. Sterbis may publish in the future.

Co-authorship network of co-authors of Joseph R. Sterbis

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph R. Sterbis. A scholar is included among the top collaborators of Joseph R. Sterbis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph R. Sterbis. Joseph R. Sterbis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
McMann, Leah P., et al.. (2019). Routine Prescription of Opioids for Post-Vasectomy Pain Control Associated with Persistent Use. The Journal of Urology. 202(4). 806–810. 17 indexed citations
3.
Hurwitz, Lauren M., Jennifer Cullen, Erika M. Wolff, et al.. (2017). A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy. Urologic Oncology Seminars and Original Investigations. 35(5). 234–242. 14 indexed citations
4.
Huang, Jeffrey, et al.. (2017). Intravesical ALT-803 for BCG-unresponsive Bladder Cancer – A Case Report. Urology Case Reports. 14. 15–17. 16 indexed citations
5.
Lustik, Michael B., et al.. (2016). Preoperative Albumin Is Predictive of Early Postoperative Morbidity and Mortality in Common Urologic Oncologic Surgeries. Clinical Genitourinary Cancer. 15(2). e255–e262. 24 indexed citations
6.
Jeldres, Claudio, Jennifer Cullen, Lauren M. Hurwitz, et al.. (2015). Prospective quality‐of‐life outcomes for low‐risk prostate cancer: Active surveillance versus radical prostatectomy. Cancer. 121(14). 2465–2473. 44 indexed citations
7.
McMann, Leah P., et al.. (2015). Penile Squamous Cell Carcinoma After a Childhood Hypospadias Repair With Bladder Mucosa Graft. Urology. 85(6). 1471–1473.
8.
Sterbis, Joseph R., et al.. (2015). Leydig cell hyperplasia in the setting of Klinefelter syndrome. BMJ Case Reports. 2015. bcr2015209805–bcr2015209805. 5 indexed citations
9.
Sterbis, Joseph R., et al.. (2014). Prostate Cancer Nomograms: A Review of Their Use in Cancer Detection and Treatment. Current Urology Reports. 15(3). 391–391. 18 indexed citations
10.
Lustik, Michael B., et al.. (2014). Comparison of outcomes after TURP versus photoselective vaporization of the prostate with respect to trainee involvement utilizing ACS NSQIP. Prostate Cancer and Prostatic Diseases. 17(3). 227–232. 6 indexed citations
11.
Sterbis, Joseph R., et al.. (2014). Postcoital Hemorrhage of a Recurrent Seminal Vesicle Cyst Requiring Embolization. Urology Case Reports. 2(5). 171–172. 1 indexed citations
14.
Rice, Kevin R., Joseph R. Sterbis, Yongmei Chen, et al.. (2011). Prostate Cancer in Men Less Than the Age of 50: A Comparison of Race and Outcomes. Urology. 78(1). 110–115. 44 indexed citations
15.
Sterbis, Joseph R., Kevin R. Rice, Marcia C. Javitt, Noah S. Schenkman, & Stephen A. Brassell. (2010). Fusion Imaging: A Novel Staging Modality in Testis Cancer. Journal of Cancer. 1. 223–229. 12 indexed citations
16.
Ravindranath, Lakshmi, Bungo Furusato, Ying Hu, et al.. (2009). Quantitative expression of TMPRSS2 transcript in prostate tumor cells reflects TMPRSS2–ERG fusion status. Prostate Cancer and Prostatic Diseases. 13(1). 47–51. 21 indexed citations
17.
Sterbis, Joseph R., Chunling Gao, Bungo Furusato, et al.. (2008). Higher Expression of the Androgen-Regulated Gene PSA/HK3 mRNA in Prostate Cancer Tissues Predicts Biochemical Recurrence-Free Survival. Clinical Cancer Research. 14(3). 758–763. 18 indexed citations
18.
Sterbis, Joseph R., Eric J. Hanly, Michael R. Marohn, et al.. (2008). Transcontinental Telesurgical Nephrectomy Using the da Vinci Robot in a Porcine Model. Urology. 71(5). 971–973. 75 indexed citations
19.
Sterbis, Joseph R., et al.. (2006). A Unique Presentation of Appendicitis: F-18 FDG PET/CT. Clinical Nuclear Medicine. 31(11). 704–706. 20 indexed citations
20.
Sterbis, Joseph R., Stephen A. Brassell, & David G. McLeod. (2005). Perioperative Complications of Radical Retropubic Prostatectomy. Clinical Genitourinary Cancer. 4(3). 160–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026